David Tyronne Howton, Jr
2019
Compensation breakdown
| Non-Equity Incentive Plan | $259,636 |
|---|---|
| Option Awards | $3,464,825 |
| Salary | $458,844 |
| Other | $13,318 |
| Total | $4,196,622 |
Howton received $3.5M in option awards, accounting for 83% of the total pay in 2019.
Howton also received $259.6K in non-equity incentive plan, $458.8K in salary and $13.3K in other compensation.
Rankings
In 2019, David Tyronne Howton, Jr's compensation ranked 2,808th out of 13,971 executives tracked by ExecPay. In other words, Howton earned more than 79.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,808 out of 13,971 | 80th |
Division Manufacturing | 1,015 out of 5,701 | 82nd |
Major group Chemicals And Allied Products | 335 out of 2,200 | 85th |
Industry group Drugs | 272 out of 1,886 | 86th |
Industry Pharmaceutical Preparations | 201 out of 1,398 | 86th |
Pay ratio
| David Tyronne Howton, Jr's Pay | $4,196,622 |
|---|---|
| Median Employee's Pay | $290,714 |
| Pay Ratio | 14to 1 |
In 2019, the annual total compensation of David Tyronne Howton, Jr was $4,196,622.
The annual total compensation of the median employee at Sarepta Therapeutics was $290,714.
The ratio of David Tyronne Howton, Jr's pay to the pay of median employee was therefore 14 to one.
Howton's colleagues
We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2019.